Ampio Pharmaceuticals (AMEX:AMPE) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.02) by 100 percent. This is a 100 percent decrease over losses of $(0.02) per share from the same period last year.
KE Holdings Q3 EPS $0.22 Beats $0.12 Estimate, Sales $2.47B Beat $2.38B Estimate
KE Holdings (NYSE:BEKE) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.12 by 83.33 percent. The company reported quarterly sales of $2.47 billion which beat the analyst
